Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations.

Kitagawa A, Izumi Y, Hagihara M, Kamei S, Ikeda S, Katsuda E, Kimura J, Ota T, Ishiguchi T.

Cardiovasc Intervent Radiol. 2014 Apr;37(2):371-80. doi: 10.1007/s00270-013-0653-8. Epub 2013 Jun 5. Erratum in: Cardiovasc Intervent Radiol. 2014 Feb;37(1):284-5.

PMID:
23737022
2.

Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification.

Cho SK, Do YS, Shin SW, Kim DI, Kim YW, Park KB, Kim EJ, Ahn HJ, Choo SW, Choo IW.

J Endovasc Ther. 2006 Aug;13(4):527-38.

PMID:
16928170
3.

High-flow arteriovenous malformation of the lower extremity: ethanolamine oleate sclerotherapy.

Hyodoh H, Fujita A, Hyodoh K, Furuse M, Kamisawa O, Hareyama M.

Cardiovasc Intervent Radiol. 2001 Sep-Oct;24(5):348-51.

PMID:
11815844
4.

Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate.

Choi YH, Han MH, O-Ki K, Cha SH, Chang KH.

J Vasc Interv Radiol. 2002 May;13(5):475-82.

PMID:
11997355
5.

Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck.

Kaji N, Kurita M, Ozaki M, Takushima A, Harii K, Narushima M, Wakita S.

Scand J Plast Reconstr Surg Hand Surg. 2009;43(3):126-36. doi: 10.1080/02844310902840296.

PMID:
19401940
6.

Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck.

Alexander MD, McTaggart RA, Choudhri OA, Marcellus ML, Do HM.

J Neurointerv Surg. 2014 Nov;6(9):695-8. doi: 10.1136/neurintsurg-2013-010924. Epub 2013 Nov 14.

PMID:
24235099
7.

Transcatheter Arterial Embolization with n-Butyl Cyanoacrylate for the Treatment of Acquired Uterine Vascular Malformations.

Picel AC, Koo SJ, Roberts AC.

Cardiovasc Intervent Radiol. 2016 Aug;39(8):1170-6. doi: 10.1007/s00270-016-1328-z. Epub 2016 Mar 28.

PMID:
27021069
8.

Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.

Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K.

Endoscopy. 1995 Jun;27(5):349-54.

PMID:
7588347
9.

Effects of blood flow control on clinical outcomes after ethanolamine oleate sclerotherapy for vascular malformations.

Hyodoh H, Akiba H, Hyodoh K, Ezoe K, Yotsuyanagi T, Hareyama M.

Jpn J Radiol. 2009 Oct;27(8):297-302. doi: 10.1007/s11604-009-0341-4. Epub 2009 Oct 27.

PMID:
19856224
10.

Advanced management of congenital vascular malformations: a multidisciplinary approach.

Lee BB, Bergan JJ.

Cardiovasc Surg. 2002 Dec;10(6):523-33.

PMID:
12453680
11.

How do we treat arteriovenous malformations (tips and tricks)?

Do YS, Park KB, Cho SK.

Tech Vasc Interv Radiol. 2007 Dec;10(4):291-8. doi: 10.1053/j.tvir.2008.03.008.

PMID:
18572144
12.

Percutaneous transhepatic portal embolization using foam ethanolamine oleate and carbon dioxide (CO₂): a pilot study.

Inoue S, Ikeda O, Nakasone Y, Beppu T, Masuda T, Yokoyama K, Utsunomiya D, Baba H, Yamashita Y.

Acta Radiol. 2015 Nov;56(11):1361-7. doi: 10.1177/0284185115590285. Epub 2015 Jun 24.

PMID:
26113740
13.

Ethanol embolotherapy of foot arteriovenous malformations.

Hyun D, Do YS, Park KB, Kim DI, Kim YW, Park HS, Shin SW, Song YG.

J Vasc Surg. 2013 Dec;58(6):1619-26. doi: 10.1016/j.jvs.2013.06.074.

14.

Ethanol embolization of arteriovenous malformations: interim results.

Do YS, Yakes WF, Shin SW, Lee BB, Kim DI, Liu WC, Shin BS, Kim DK, Choo SW, Choo IW.

Radiology. 2005 May;235(2):674-82.

PMID:
15858106
15.

Endovascular treatment combined with emboloscleorotherapy for pelvic arteriovenous malformations.

Do YS, Kim YW, Park KB, Kim DI, Park HS, Cho SK, Shin SW, Park YJ.

J Vasc Surg. 2012 Feb;55(2):465-71. doi: 10.1016/j.jvs.2011.08.051. Epub 2011 Nov 1.

16.

A successful case of transcatheter arterial embolization with n-butyl-2-cyanoacrylate for pancreatic arteriovenous malformation.

Tatsuta T, Endo T, Watanabe K, Hasui K, Sawada N, Igarashi G, Mikami K, Shibutani K, Tsushima F, Takai Y, Fukuda S.

Intern Med. 2014;53(23):2683-7. Epub 2014 Dec 1. Review.

17.

Embolization of cerebral arteriovenous malformations with n-butyl-2-cyanoacrylate.

Liu HM, Huang YC, Wang YH.

J Formos Med Assoc. 2000 Dec;99(12):906-13.

PMID:
11155743
18.

Management of arteriovenous malformations: a multidisciplinary approach.

Lee BB, Do YS, Yakes W, Kim DI, Mattassi R, Hyon WS.

J Vasc Surg. 2004 Mar;39(3):590-600.

19.

Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.

Alexander MD, McTaggart RA, Choudhri OA, Marcellus ML, Do HM.

J Neurointerv Surg. 2014 Nov;6(9):691-4. doi: 10.1136/neurintsurg-2013-010925. Epub 2013 Oct 23.

PMID:
24153336
20.

The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices.

Thakeb F, Salama Z, Salama H, Abdel Raouf T, Abdel Kader S, Abdel Hamid H.

Endoscopy. 1995 Jun;27(5):358-64.

PMID:
7588349

Supplemental Content

Support Center